Monte Carlo vs Immuta

Side-by-side comparison of model-estimated upside.

Monte Carlo

-52%

est. 2Y upside i

AI & MLSeries D+

Rank

#3289

Sector

Data and AI Observability

Est. Liquidity

~3Y

Data Quality

Data: Low

Given a stale $1.6B valuation and 19.6x revenue multiple, projected flat to declining revenues relative to valuation, with 20% expected dilution and no near-term IPO, the equity is likely negative over a 2-year horizon.

Last updated: July 19, 2026

Immuta

-36%

est. 2Y upside i

CybersecuritySeries D+

Rank

#3097

Sector

Cybersecurity

Est. Liquidity

~4Y

Data Quality

Data: Medium

The equity outlook is highly risky: the stale $1B valuation (42x revenue) leaves limited upside even with strong growth, and a likely dilutive raise plus preference overhang make negative returns probable.

Last updated: July 21, 2026

Upside Comparison

Expected Upside

Monte Carlo

-52%

Immuta

-36%

Disclaimer: These rankings are AI-generated estimates and do not constitute financial or career advice. Always conduct your own due diligence.